Diabetes decisions — 2025

The Board denied the Veteran's claim for service connection for diabetes mellitus, type II, as there was no evidence of an in-service injury or disease and the condition did not manifest within one year of service.

The Board denied service connection for diabetes mellitus type II, bilateral lower extremity and upper extremity peripheral neuropathy, GERD, hypertension, OSA, and a compensable rating for bilateral hearing loss.

The Board granted service connection for coronary artery disease with myocardial infarction, diabetes mellitus type II, right and left lower extremity peripheral neuropathy, unspecified anxiety disorder (claimed as post-traumatic stress disorder), sleep apnea, and an initial 10 percent rating for hypertension.

The Board remands the Veteran's claims for service connection for diabetes mellitus, heart disability, and chloracne due to pre-decisional duty to assist errors.

The Board granted service connection for the cause of death, finding that the Veteran's end-stage chronic kidney disease, diabetes mellitus, hypertensive atherosclerotic cardiovascular disease, and obstructive sleep apnea contributed substantially or materially to his death.

The appeal was dismissed due to the Veteran's death.

The Board denied the veteran's claims for a higher disability rating for diabetes mellitus and entitlement to total disability based on individual unemployability (TDIU).

The Board remands the claims for a compensable rating and service connection due to a pre-decisional duty to assist error and an inadequate medical opinion.

The Board denied the veteran's claims for an earlier effective date and higher initial ratings for type II diabetes mellitus and hypothyroidism, as there was no evidence of a claim prior to October 2, 2023, and the evidence did not support entitlement to a higher rating.

The Board remands the claim for service connection of diabetes mellitus type II to ensure compliance with previous remand directives, including obtaining an addendum opinion regarding the nature and etiology of the Veteran's condition.

The Board remands the claims for service connection for diabetes mellitus type II, hypertension, and peripheral neuropathy of both lower extremities due to a pre-decisional duty-to-assist error regarding VA examination scheduling.

The Board remands the claims for service connection for diabetes mellitus type II and obstructive sleep apnea to obtain an adequate medical opinion addressing the Veteran's lay statements regarding her service-connected disabilities causing pain, preventing exercise, leading to obesity, and subsequently resulting in these conditions.

The Board denied service connection for diabetes mellitus, right and left shoulder and knee joint pain, a sciatic nerve disability, and an earlier effective date for non-allergic rhinitis with recurrent sinusitis and deviated septum. The claims for right and left ankle joint pain were remanded.

The Board denied earlier effective dates for the grants of service connection and special monthly compensation, as these claims were granted under the PACT Act on August 10, 2022.

The Board granted service connection for a right hip disability and diabetes mellitus type II (DMII) both secondary to the Veteran's service-connected bilateral foot disabilities.

The Board remands the appeal for further development, including obtaining outstanding treatment records and scheduling additional examinations.

The Board granted service connection for diabetes mellitus, type II and bilateral lower extremity diabetic peripheral neuropathy based on the Veteran's in-service exposure to industrial cleaning chemicals.

The Board granted a 40 percent disability rating for diabetes mellitus effective August 7, 2018, and denied an earlier effective date for the award of service connection for PTSD.

The Veteran was granted an initial 70 percent rating for PTSD from November 12, 2009 through May 30, 2011.

The Board granted service connection for erectile dysfunction and special monthly compensation based on loss of use of a creative organ, while remanding the claims for obstructive sleep apnea, lumbar spine disorder, left ankle disorder, and diabetes mellitus type 2.